Intermediate-dose cytarabine as a safer consolidation strategy for acute myeloid leukemia. Sakai T, Miyao K, Kiwada T, Ozaki S, et al. Int J Hematol 2025 Dec 26. doi: 10.1007/s12185-025-04141.

Read + Share

Amedeo Smart

Independent Medical Education

Sakai T, Miyao K, Kiwada T, Ozaki S, et al. Intermediate-dose cytarabine as a safer consolidation strategy for acute myeloid leukemia. Int J Hematol 2025 Dec 26. doi: 10.1007/s12185-025-04141.
PMID: 41452480